Home › Funds › RASP WEALTH SOLUTIONS, LLC › LLY
RASP WEALTH SOLUTIONS, LLC position in LLY
Eli Lilly & Co · Health Care
RASP WEALTH SOLUTIONS, LLC reported holding 130,286 shares of LLY (Eli Lilly & Co) in its Q3 2026 13F filing — a position valued at US$150.8M, representing 59.24% of its reported portfolio and ranking #1 among its reported holdings. RASP WEALTH SOLUTIONS, LLC has disclosed LLY holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR
How RASP WEALTH SOLUTIONS, LLC's LLY position evolved
RASP WEALTH SOLUTIONS, LLC first disclosed a stake in LLY in Q2 2026 at 169,743 shares (US$203.6M). Across 2 filings, RASP WEALTH SOLUTIONS, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 130,286 shares valued at US$150.8M — a reduction of -39,457 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 169.74K | $203.60M | New |
| Q3 2026 | 130.29K | $150.75M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LLY and 13F data
LLY (Eli Lilly & Co) is a Health Care company. 38 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), BlackRock Inc (US$81.01B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LLY
- LILLY ENDOWMENT INC 90.07M sh · $104.21B · Q3 2026
- Vanguard Group 81.97M sh · $88.09B · Q4 2025
- BlackRock Inc 67.54M sh · $81.01B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 53.53M sh · $64.20B · Q2 2026
- PNC Financial Services 51.32M sh · $61.56B · Q2 2026
- Fidelity Management & Research (FMR) 28.46M sh · $34.14B · Q2 2026
- STATE STREET CORP 35.61M sh · $32.75B · Q1 2026
- Capital Research Global Investors 20.87M sh · $25.04B · Q2 2026
- Capital Research Global Investors 20.87M sh · $25.04B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 20.86M sh · $25.02B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 20.31M sh · $24.28B · Q2 2026
- Geode Capital Management 20.31M sh · $24.28B · Q2 2026
More on RASP WEALTH SOLUTIONS, LLC
FAQ
How long has RASP WEALTH SOLUTIONS, LLC held LLY?
RASP WEALTH SOLUTIONS, LLC has disclosed LLY holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is RASP WEALTH SOLUTIONS, LLC's current position in LLY?
As of Q3 2026, RASP WEALTH SOLUTIONS, LLC holds 130.29K shares of LLY (Eli Lilly & Co), valued at $150.75M, representing 59.24% of its reported portfolio and ranking #1.
Has RASP WEALTH SOLUTIONS, LLC been buying or selling LLY?
In the latest 13F filing (Q3 2026), RASP WEALTH SOLUTIONS, LLC reduced its position in LLY.
Which other funds hold LLY?
Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, BlackRock Inc, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.